BR112012021805A2 - dispositivo de eletroporação de pele tolerável e minimamente invasivo - Google Patents
dispositivo de eletroporação de pele tolerável e minimamente invasivoInfo
- Publication number
- BR112012021805A2 BR112012021805A2 BR112012021805A BR112012021805A BR112012021805A2 BR 112012021805 A2 BR112012021805 A2 BR 112012021805A2 BR 112012021805 A BR112012021805 A BR 112012021805A BR 112012021805 A BR112012021805 A BR 112012021805A BR 112012021805 A2 BR112012021805 A2 BR 112012021805A2
- Authority
- BR
- Brazil
- Prior art keywords
- tolerable
- electroporation device
- minimally invasive
- invasive skin
- skin electroporation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0502—Skin piercing electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Radiology & Medical Imaging (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Electrotherapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30942210P | 2010-03-01 | 2010-03-01 | |
| PCT/US2011/026701 WO2011109406A1 (en) | 2010-03-01 | 2011-03-01 | A tolerable and minimally invasive skin electroporation device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012021805A2 true BR112012021805A2 (pt) | 2016-05-17 |
Family
ID=44542539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012021805A BR112012021805A2 (pt) | 2010-03-01 | 2011-03-01 | dispositivo de eletroporação de pele tolerável e minimamente invasivo |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11565107B2 (enExample) |
| EP (1) | EP2542300B1 (enExample) |
| JP (1) | JP5706451B2 (enExample) |
| KR (1) | KR101872408B1 (enExample) |
| CN (1) | CN102905755B (enExample) |
| AU (1) | AU2011223753B2 (enExample) |
| BR (1) | BR112012021805A2 (enExample) |
| CA (1) | CA2789736A1 (enExample) |
| DK (1) | DK2542300T3 (enExample) |
| EA (1) | EA025705B1 (enExample) |
| ES (1) | ES2594498T3 (enExample) |
| MX (1) | MX2012009986A (enExample) |
| PL (1) | PL2542300T3 (enExample) |
| PT (1) | PT2542300T (enExample) |
| WO (1) | WO2011109406A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015203882C1 (en) * | 2011-06-28 | 2017-09-21 | Inovio Pharmaceuticals, Inc. | A minimally invasive dermal electroporation device |
| KR102171142B1 (ko) * | 2011-06-28 | 2020-10-28 | 이노비오 파마수티컬즈, 인크. | 최소 침습 피부 전기천공 장치 |
| US11013917B2 (en) | 2013-06-21 | 2021-05-25 | Newsouth Innovations Pty Limited | Method and apparatus for close-field electroporation |
| CN104689478A (zh) * | 2013-12-09 | 2015-06-10 | 深圳市瑞吉思科技有限公司 | 细胞再生仪 |
| CN103861202B (zh) | 2014-03-18 | 2016-06-01 | 苏州壹达生物科技有限公司 | 一种利用空心电极针电穿孔给药的装置 |
| WO2016161201A2 (en) * | 2015-03-31 | 2016-10-06 | Oncosec Medical Incorporated | Systems and methods for improved tissue-sensing based electroporation |
| AU2016381186B2 (en) | 2015-12-30 | 2022-01-20 | Inovio Pharmaceuticals, Inc. | Electroporation device with detachable needle array with lock-out system |
| WO2018064463A1 (en) * | 2016-09-30 | 2018-04-05 | University Of Florida Research Foundation, Inc. | Systems and methods including porous membrane for low-voltage continuous cell electroporation |
| CN107890608A (zh) * | 2017-12-01 | 2018-04-10 | 王嘉浩 | 淋巴细胞增升仪 |
| BR112021012548A2 (pt) * | 2019-02-04 | 2021-09-14 | Rutgers, The State University Of New Jersey | Dispositivo para eletrotransferência de tecido com o uso de um microelétrodo |
| US11071860B2 (en) | 2019-02-06 | 2021-07-27 | Oncosec Medical Incorporated | Systems and methods for detecting fault conditions in electroporation therapy |
| BR102019013578A2 (pt) * | 2019-06-28 | 2021-01-05 | Eqt Equipamentos E Tecnologia Ltda. | Ponta aplicadora de eletroporação para procedimento de eletroquimioterapia |
| KR102576604B1 (ko) | 2021-02-16 | 2023-09-08 | 주식회사 밀알 | 의료용 정밀 약물주입 및 전기천공 융합 전극 |
| KR20220159203A (ko) | 2021-05-25 | 2022-12-02 | 주식회사 밀알 | 의료용 정밀 약물주입 및 전기천공 융합 전극 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3994287A (en) * | 1974-07-01 | 1976-11-30 | Centre De Recherche Industrielle Du Quebec | Trocar |
| US5273525A (en) | 1992-08-13 | 1993-12-28 | Btx Inc. | Injection and electroporation apparatus for drug and gene delivery |
| US6277116B1 (en) * | 1994-05-06 | 2001-08-21 | Vidaderm | Systems and methods for shrinking collagen in the dermis |
| ATE241405T1 (de) * | 1996-07-03 | 2003-06-15 | Altea Therapeutics Corp | Mehrfache mechanische mikroperforierung von haut oder schleimhäuten |
| US6261281B1 (en) | 1997-04-03 | 2001-07-17 | Electrofect As | Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
| AU733628B2 (en) | 1997-04-03 | 2001-05-17 | Electrofect As | Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle |
| JP2002507985A (ja) | 1997-06-30 | 2002-03-12 | ローヌ−プーラン・ロレ・エス・アー | 横紋筋に核酸を導入する改良法およびその組合せ |
| US6241701B1 (en) * | 1997-08-01 | 2001-06-05 | Genetronics, Inc. | Apparatus for electroporation mediated delivery of drugs and genes |
| TW368420B (en) * | 1997-11-04 | 1999-09-01 | Genetronics Inc | Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum |
| US7922709B2 (en) * | 1998-07-13 | 2011-04-12 | Genetronics, Inc. | Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation |
| EP1163024B1 (en) * | 1999-01-28 | 2003-12-17 | Cyto Pulse Sciences, Inc. | Delivery of macromolecules into cells |
| US6678558B1 (en) * | 1999-03-25 | 2004-01-13 | Genetronics, Inc. | Method and apparatus for reducing electroporation-mediated muscle reaction and pain response |
| US7113821B1 (en) * | 1999-08-25 | 2006-09-26 | Johnson & Johnson Consumer Companies, Inc. | Tissue electroperforation for enhanced drug delivery |
| US20070016268A1 (en) | 2000-01-07 | 2007-01-18 | John Carter | Percutaneous electrode array |
| US7245963B2 (en) * | 2002-03-07 | 2007-07-17 | Advisys, Inc. | Electrode assembly for constant-current electroporation and use |
| US6912417B1 (en) | 2002-04-05 | 2005-06-28 | Ichor Medical Systmes, Inc. | Method and apparatus for delivery of therapeutic agents |
| AU2003226605A1 (en) * | 2002-04-19 | 2003-11-03 | Transpharma Medical Ltd. | Handheld transdermal drug delivery and analyte extraction |
| US20060036210A1 (en) | 2004-06-30 | 2006-02-16 | Lei Zhang | Modular electroporation device with disposable electrode and drug delivery components |
| US20100168501A1 (en) * | 2006-10-02 | 2010-07-01 | Daniel Rogers Burnett | Method and apparatus for magnetic induction therapy |
| US10369359B2 (en) | 2006-02-11 | 2019-08-06 | Genetronics, Inc. | Device and method for single-needle in vivo electroporation |
| CN101563132A (zh) * | 2006-10-17 | 2009-10-21 | Vgx药品公司 | 电穿孔装置及用其进行哺乳动物细胞电穿孔的方法 |
| JP2010516815A (ja) | 2007-01-31 | 2010-05-20 | ヘラー， アダム | 疼痛の治療のための方法および組成物 |
-
2011
- 2011-03-01 MX MX2012009986A patent/MX2012009986A/es active IP Right Grant
- 2011-03-01 KR KR1020127025208A patent/KR101872408B1/ko active Active
- 2011-03-01 PT PT117512087T patent/PT2542300T/pt unknown
- 2011-03-01 BR BR112012021805A patent/BR112012021805A2/pt active IP Right Grant
- 2011-03-01 EP EP11751208.7A patent/EP2542300B1/en active Active
- 2011-03-01 JP JP2012556176A patent/JP5706451B2/ja active Active
- 2011-03-01 PL PL11751208T patent/PL2542300T3/pl unknown
- 2011-03-01 WO PCT/US2011/026701 patent/WO2011109406A1/en not_active Ceased
- 2011-03-01 CN CN201180011473.6A patent/CN102905755B/zh active Active
- 2011-03-01 CA CA2789736A patent/CA2789736A1/en active Pending
- 2011-03-01 ES ES11751208.7T patent/ES2594498T3/es active Active
- 2011-03-01 US US13/581,702 patent/US11565107B2/en active Active
- 2011-03-01 DK DK11751208.7T patent/DK2542300T3/en active
- 2011-03-01 AU AU2011223753A patent/AU2011223753B2/en active Active
- 2011-03-01 EA EA201201203A patent/EA025705B1/ru not_active IP Right Cessation
-
2022
- 2022-07-25 US US17/814,703 patent/US12491361B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EA201201203A1 (ru) | 2013-04-30 |
| HK1181339A1 (zh) | 2013-11-08 |
| US20230145532A1 (en) | 2023-05-11 |
| PT2542300T (pt) | 2016-11-14 |
| WO2011109406A1 (en) | 2011-09-09 |
| EP2542300B1 (en) | 2016-08-10 |
| US11565107B2 (en) | 2023-01-31 |
| ES2594498T3 (es) | 2016-12-20 |
| US20130066296A1 (en) | 2013-03-14 |
| EP2542300A1 (en) | 2013-01-09 |
| KR101872408B1 (ko) | 2018-06-28 |
| US12491361B2 (en) | 2025-12-09 |
| DK2542300T3 (en) | 2016-11-28 |
| EA025705B1 (ru) | 2017-01-30 |
| CA2789736A1 (en) | 2011-09-09 |
| MX2012009986A (es) | 2012-11-21 |
| AU2011223753A1 (en) | 2012-09-13 |
| EP2542300A4 (en) | 2013-11-13 |
| PL2542300T3 (pl) | 2017-06-30 |
| JP5706451B2 (ja) | 2015-04-22 |
| JP2013521058A (ja) | 2013-06-10 |
| KR20130020662A (ko) | 2013-02-27 |
| CN102905755A (zh) | 2013-01-30 |
| AU2011223753B2 (en) | 2014-06-26 |
| CN102905755B (zh) | 2016-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012021805A2 (pt) | dispositivo de eletroporação de pele tolerável e minimamente invasivo | |
| AR117136A2 (es) | Aparato generador electrohidráulico (eh) de ondas de choque de pulsos rápidos, y métodos para tratamientos médicos y cosméticos | |
| MX2015010880A (es) | Combinacion de vacunacion e inhibicion de la trayectoria pd-1. | |
| MX2015011296A (es) | Dispositivo foto-terapeutico, metodo y uso. | |
| MX2012013731A (es) | Vacunas que comprenden colesterol y cpg como moleculas portadoras-adyuvantes unicas. | |
| IN2015DN01883A (enExample) | ||
| PL2640352T3 (pl) | Hydrolizat kolagenu do zastosowania do poprawy zdrowia ludzkiej skóry, włosów i/lub paznokci | |
| NZ627078A (en) | Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy | |
| MX345704B (es) | Vacuna bovinas y métodos. | |
| PE20151588A1 (es) | Vacuna contra el virus del dengue | |
| CL2016000544A1 (es) | Composición cosmética que comprende 0,0001 a 10% en peso de extracto de guacatonga (casearia sylvestris) y 0,00005 a 10% en peso de extracto de aroeira (schinus terebinthifolius raddi) ambos respecto al peso total de la composición; uso de la composición en la prevención y/o tratamiento de los signos de envejicimiento de la piel; metodo para prevenir y/o tratar los signos de envejecimiento de la piel. | |
| BR112014002595A2 (pt) | uso de esfinganina para melhorar a aparência visual da pele e cabelo | |
| MX381211B (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
| BR112015021523A8 (pt) | composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis | |
| IN2015MN00038A (enExample) | ||
| NZ715430A (en) | Mammalian milk osteopontin for enhancing immune responsiveness | |
| CA144117S (en) | Disposable applicator tip for use on a medical device designed to reduce or remove sweat glands and hair follicles | |
| BR112015029815A2 (pt) | composição cosmética para clarear uma pele e/ou cabelo de um indivíduo, conjunto para clarear uma pele e/ou um cabelo de um individuo, método cosmético para clarear uma pele e/ou um cabelo de um individuo, composição cosmética ou farmacêutica para aplicação na pele, cabelo e/ou unha de um indivíduo, conjunto para aplicar uma composição cosmética ou farmacêutica na pele cabelo e/ou unha de um individuo e método de administração de peróxido de hidrogênio na pele, cabelo e/ou unha de indivíduo. | |
| BR112014020025A2 (pt) | vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas | |
| MX2017015418A (es) | Composiciones y metodos de uso de beta-hidroxi-beta-metilbutirato (hmb) para reducir grasa corporal. | |
| MX2016001686A (es) | Composicion para el tratamiento contra el envejecimiento de la piel. | |
| AR093424A1 (es) | Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso | |
| ATE529131T1 (de) | Impfung mittels gezielter transkutaner freisetzung | |
| ES2670493T3 (es) | Vacuna de MTB-C contra respuestas alérgicas | |
| CU20130041A7 (es) | Micobacteria recombinante como vacuna contra la tuberculosis para uso en humanos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/03/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |